1. Home
  2. MRNA vs FLR Comparison

MRNA vs FLR Comparison

Compare MRNA & FLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • FLR
  • Stock Information
  • Founded
  • MRNA 2010
  • FLR 1912
  • Country
  • MRNA United States
  • FLR United States
  • Employees
  • MRNA N/A
  • FLR N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • FLR Military/Government/Technical
  • Sector
  • MRNA Health Care
  • FLR Industrials
  • Exchange
  • MRNA Nasdaq
  • FLR Nasdaq
  • Market Cap
  • MRNA 9.8B
  • FLR 7.9B
  • IPO Year
  • MRNA 2018
  • FLR N/A
  • Fundamental
  • Price
  • MRNA $27.16
  • FLR $48.77
  • Analyst Decision
  • MRNA Hold
  • FLR Buy
  • Analyst Count
  • MRNA 15
  • FLR 7
  • Target Price
  • MRNA $37.15
  • FLR $49.43
  • AVG Volume (30 Days)
  • MRNA 10.8M
  • FLR 3.9M
  • Earning Date
  • MRNA 11-06-2025
  • FLR 11-07-2025
  • Dividend Yield
  • MRNA N/A
  • FLR N/A
  • EPS Growth
  • MRNA N/A
  • FLR 970.51
  • EPS
  • MRNA N/A
  • FLR 24.07
  • Revenue
  • MRNA $3,078,000,000.00
  • FLR $16,313,000,000.00
  • Revenue This Year
  • MRNA N/A
  • FLR $3.29
  • Revenue Next Year
  • MRNA $11.12
  • FLR $3.99
  • P/E Ratio
  • MRNA N/A
  • FLR $2.03
  • Revenue Growth
  • MRNA N/A
  • FLR 3.61
  • 52 Week Low
  • MRNA $23.15
  • FLR $29.20
  • 52 Week High
  • MRNA $56.70
  • FLR $60.10
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 52.43
  • FLR 57.27
  • Support Level
  • MRNA $24.25
  • FLR $45.34
  • Resistance Level
  • MRNA $29.20
  • FLR $50.90
  • Average True Range (ATR)
  • MRNA 1.44
  • FLR 2.20
  • MACD
  • MRNA -0.03
  • FLR 0.04
  • Stochastic Oscillator
  • MRNA 58.79
  • FLR 51.12

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About FLR Fluor Corporation

Fluor is one of the largest global providers of engineering, procurement, construction, fabrication, operations, and maintenance services.It serves a wide range of end markets, including oil and gas, chemicals, mining, metals, and transportation. The company's business is organized into three core segments: urban solutions, mission solutions, and energy solutions. Fluor generated $16.3 billion in revenue in 2024.

Share on Social Networks: